HEADER TRANSFERASE 08-SEP-06 2J4Z TITLE STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA-680626 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE THREONINE-PROTEIN KINASE 6; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 100-403; COMPND 5 SYNONYM: SERINE/THREONINE KINASE 15, AURORA/IPL1-RELATED KINASE 1, COMPND 6 AURORA-RELATED KINASE 1, HARK1, AURORA-A, BREAST-TUMOR-AMPLIFIED COMPND 7 KINASE; COMPND 8 EC: 2.7.1.37, 2.7.11.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: HIGH FIVE; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE, PHOSPHORYLATION, NUCLEOTIDE-BINDING, KINASE, CELL CYCLE, KEYWDS 2 ATP-BINDING, NUCLEOTIDE- BINDING, SERINE/THREONINE-PROTEIN KINASE, KEYWDS 3 SERINE-THREONINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR A.D.CAMERON,G.IZZO,P.STORICI,L.RUSCONI,D.FANCELLI,M.VARASI,D.BERTA, AUTHOR 2 S.BINDI,B.FORTE,D.SEVERINO,R.TONANI,P.VIANELLO REVDAT 7 13-DEC-23 2J4Z 1 REMARK LINK REVDAT 6 03-APR-19 2J4Z 1 SOURCE REVDAT 5 16-JAN-19 2J4Z 1 JRNL REMARK REVDAT 4 05-MAY-09 2J4Z 1 REMARK REVDAT 3 24-FEB-09 2J4Z 1 VERSN REVDAT 2 30-NOV-06 2J4Z 1 JRNL REVDAT 1 06-NOV-06 2J4Z 0 JRNL AUTH D.FANCELLI,J.MOLL,M.VARASI,R.BRAVO,R.ARTICO,D.BERTA,S.BINDI, JRNL AUTH 2 A.CAMERON,I.CANDIANI,P.CAPPELLA,P.CARPINELLI,W.CROCI, JRNL AUTH 3 B.FORTE,M.L.GIORGINI,J.KLAPWIJK,A.MARSIGLIO,E.PESENTI, JRNL AUTH 4 M.ROCCHETTI,F.ROLETTO,D.SEVERINO,C.SONCINI,P.STORICI, JRNL AUTH 5 R.TONANI,P.ZUGNONI,P.VIANELLO JRNL TITL 1,4,5,6-TETRAHYDROPYRROLO[3,4-C]PYRAZOLES: IDENTIFICATION OF JRNL TITL 2 A POTENT AURORA KINASE INHIBITOR WITH A FAVORABLE ANTITUMOR JRNL TITL 3 KINASE INHIBITION PROFILE. JRNL REF J. MED. CHEM. V. 49 7247 2006 JRNL REFN ISSN 0022-2623 JRNL PMID 17125279 JRNL DOI 10.1021/JM060897W REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.58 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 41144 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2037 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2450 REMARK 3 BIN FREE R VALUE : 0.2880 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4365 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 67 REMARK 3 SOLVENT ATOMS : 194 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.48000 REMARK 3 B22 (A**2) : -5.27000 REMARK 3 B33 (A**2) : 0.79000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.15 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.17 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.780 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.550 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.420 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.360 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.640 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 46.65 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN.PARAM REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : 626.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 2J4Z COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-SEP-06. REMARK 100 THE DEPOSITION ID IS D_1290029916. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JAN-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93 REMARK 200 MONOCHROMATOR : DIAMOND (111), GE(220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41492 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.44000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2BMC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 0.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 5000MME, 0.2M SODIUM ACETATE REMARK 280 0.1M SODIUM CACODYLATE PH 6.5, 2MM DTT, PH 6.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.56350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.01850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.72250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.01850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.56350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.72250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 98 REMARK 465 PRO A 99 REMARK 465 GLN A 100 REMARK 465 PRO A 101 REMARK 465 LEU A 102 REMARK 465 PRO A 103 REMARK 465 SER A 104 REMARK 465 ALA A 105 REMARK 465 PRO A 106 REMARK 465 GLU A 107 REMARK 465 ASN A 108 REMARK 465 ASN A 109 REMARK 465 PRO A 110 REMARK 465 GLU A 111 REMARK 465 GLU A 112 REMARK 465 GLU A 113 REMARK 465 LEU A 114 REMARK 465 ALA A 115 REMARK 465 SER A 116 REMARK 465 LYS A 117 REMARK 465 GLN A 118 REMARK 465 LYS A 119 REMARK 465 ASN A 120 REMARK 465 GLU A 121 REMARK 465 GLU A 122 REMARK 465 SER A 123 REMARK 465 LYS A 124 REMARK 465 LYS A 125 REMARK 465 PRO A 390 REMARK 465 SER A 391 REMARK 465 ASN A 392 REMARK 465 CYS A 393 REMARK 465 GLN A 394 REMARK 465 ASN A 395 REMARK 465 LYS A 396 REMARK 465 GLU A 397 REMARK 465 SER A 398 REMARK 465 ALA A 399 REMARK 465 SER A 400 REMARK 465 LYS A 401 REMARK 465 GLN A 402 REMARK 465 SER A 403 REMARK 465 GLY B 98 REMARK 465 PRO B 99 REMARK 465 GLN B 100 REMARK 465 PRO B 101 REMARK 465 LEU B 102 REMARK 465 PRO B 103 REMARK 465 SER B 104 REMARK 465 ALA B 105 REMARK 465 PRO B 106 REMARK 465 GLU B 107 REMARK 465 ASN B 108 REMARK 465 ASN B 109 REMARK 465 PRO B 110 REMARK 465 GLU B 111 REMARK 465 GLU B 112 REMARK 465 GLU B 113 REMARK 465 LEU B 114 REMARK 465 ALA B 115 REMARK 465 SER B 116 REMARK 465 LYS B 117 REMARK 465 GLN B 118 REMARK 465 LYS B 119 REMARK 465 ASN B 120 REMARK 465 GLU B 121 REMARK 465 GLU B 122 REMARK 465 SER B 123 REMARK 465 LYS B 124 REMARK 465 LYS B 125 REMARK 465 LYS B 396 REMARK 465 GLU B 397 REMARK 465 SER B 398 REMARK 465 ALA B 399 REMARK 465 SER B 400 REMARK 465 LYS B 401 REMARK 465 GLN B 402 REMARK 465 SER B 403 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 389 CA C O CB CG CD CE REMARK 470 LYS A 389 NZ REMARK 470 ASN B 395 CA C O CB CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2031 O HOH A 2059 1.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 226 -34.37 79.06 REMARK 500 HIS A 254 78.66 53.27 REMARK 500 ILE A 257 49.49 -98.80 REMARK 500 ASP A 274 40.82 -108.04 REMARK 500 ALA A 281 -108.50 -96.72 REMARK 500 LEU A 364 41.38 -92.74 REMARK 500 GLN B 127 -73.92 65.46 REMARK 500 GLN B 154 -86.83 -75.32 REMARK 500 GLU B 175 -92.50 -111.73 REMARK 500 SER B 226 -44.82 77.44 REMARK 500 ARG B 251 17.36 59.74 REMARK 500 TRP B 277 94.51 62.29 REMARK 500 ASP B 307 -149.35 -134.99 REMARK 500 ASN B 392 71.45 -151.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ARS B1396 AS REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 247 SG REMARK 620 2 HOH B2026 O 93.7 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 626 A 1389 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARS A 1390 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARS A 1391 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 626 B 1395 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARS B 1396 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1MQ4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA-A PROTEIN KINASE REMARK 900 RELATED ID: 1MUO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC SERINE-THREONINE KINASE REMARK 900 RELATED ID: 1OL5 RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-A 122-403, PHOSPHORYLATED ON THR287, THR288 AND REMARK 900 BOUND TO TPX2 1-43 REMARK 900 RELATED ID: 1OL6 RELATED DB: PDB REMARK 900 STRUCTURE OF UNPHOSPHORYLATED D274N MUTANT OF AURORA-A REMARK 900 RELATED ID: 1OL7 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN AURORA-A 122-403 PHOSPHORYLATED ON THR287, THR288 REMARK 900 RELATED ID: 2BMC RELATED DB: PDB REMARK 900 AURORA-2 T287D T288D COMPLEXED WITH PHA- 680632 REMARK 900 RELATED ID: 2C6D RELATED DB: PDB REMARK 900 AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH ADPNP REMARK 900 RELATED ID: 2C6E RELATED DB: PDB REMARK 900 AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH A 5- REMARK 900 AMINOPYRIMIDINYL QUINAZOLINE INHIBITOR REMARK 900 RELATED ID: 2J50 RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA -739358 REMARK 999 REMARK 999 SEQUENCE REMARK 999 GP IS PRESENT AT START DUE TO CLONING ARTIFACT DBREF 2J4Z A 98 99 PDB 2J4Z 2J4Z 98 99 DBREF 2J4Z A 100 403 UNP O14965 STK6_HUMAN 100 403 DBREF 2J4Z B 98 99 PDB 2J4Z 2J4Z 98 99 DBREF 2J4Z B 100 403 UNP O14965 STK6_HUMAN 100 403 SEQRES 1 A 306 GLY PRO GLN PRO LEU PRO SER ALA PRO GLU ASN ASN PRO SEQRES 2 A 306 GLU GLU GLU LEU ALA SER LYS GLN LYS ASN GLU GLU SER SEQRES 3 A 306 LYS LYS ARG GLN TRP ALA LEU GLU ASP PHE GLU ILE GLY SEQRES 4 A 306 ARG PRO LEU GLY LYS GLY LYS PHE GLY ASN VAL TYR LEU SEQRES 5 A 306 ALA ARG GLU LYS GLN SER LYS PHE ILE LEU ALA LEU LYS SEQRES 6 A 306 VAL LEU PHE LYS ALA GLN LEU GLU LYS ALA GLY VAL GLU SEQRES 7 A 306 HIS GLN LEU ARG ARG GLU VAL GLU ILE GLN SER HIS LEU SEQRES 8 A 306 ARG HIS PRO ASN ILE LEU ARG LEU TYR GLY TYR PHE HIS SEQRES 9 A 306 ASP ALA THR ARG VAL TYR LEU ILE LEU GLU TYR ALA PRO SEQRES 10 A 306 LEU GLY THR VAL TYR ARG GLU LEU GLN LYS LEU SER LYS SEQRES 11 A 306 PHE ASP GLU GLN ARG THR ALA THR TYR ILE THR GLU LEU SEQRES 12 A 306 ALA ASN ALA LEU SER TYR CYS HIS SER LYS ARG VAL ILE SEQRES 13 A 306 HIS ARG ASP ILE LYS PRO GLU ASN LEU LEU LEU GLY SER SEQRES 14 A 306 ALA GLY GLU LEU LYS ILE ALA ASP PHE GLY TRP SER VAL SEQRES 15 A 306 HIS ALA PRO SER SER ARG ARG THR THR LEU CYS GLY THR SEQRES 16 A 306 LEU ASP TYR LEU PRO PRO GLU MET ILE GLU GLY ARG MET SEQRES 17 A 306 HIS ASP GLU LYS VAL ASP LEU TRP SER LEU GLY VAL LEU SEQRES 18 A 306 CYS TYR GLU PHE LEU VAL GLY LYS PRO PRO PHE GLU ALA SEQRES 19 A 306 ASN THR TYR GLN GLU THR TYR LYS ARG ILE SER ARG VAL SEQRES 20 A 306 GLU PHE THR PHE PRO ASP PHE VAL THR GLU GLY ALA ARG SEQRES 21 A 306 ASP LEU ILE SER ARG LEU LEU LYS HIS ASN PRO SER GLN SEQRES 22 A 306 ARG PRO MET LEU ARG GLU VAL LEU GLU HIS PRO TRP ILE SEQRES 23 A 306 THR ALA ASN SER SER LYS PRO SER ASN CYS GLN ASN LYS SEQRES 24 A 306 GLU SER ALA SER LYS GLN SER SEQRES 1 B 306 GLY PRO GLN PRO LEU PRO SER ALA PRO GLU ASN ASN PRO SEQRES 2 B 306 GLU GLU GLU LEU ALA SER LYS GLN LYS ASN GLU GLU SER SEQRES 3 B 306 LYS LYS ARG GLN TRP ALA LEU GLU ASP PHE GLU ILE GLY SEQRES 4 B 306 ARG PRO LEU GLY LYS GLY LYS PHE GLY ASN VAL TYR LEU SEQRES 5 B 306 ALA ARG GLU LYS GLN SER LYS PHE ILE LEU ALA LEU LYS SEQRES 6 B 306 VAL LEU PHE LYS ALA GLN LEU GLU LYS ALA GLY VAL GLU SEQRES 7 B 306 HIS GLN LEU ARG ARG GLU VAL GLU ILE GLN SER HIS LEU SEQRES 8 B 306 ARG HIS PRO ASN ILE LEU ARG LEU TYR GLY TYR PHE HIS SEQRES 9 B 306 ASP ALA THR ARG VAL TYR LEU ILE LEU GLU TYR ALA PRO SEQRES 10 B 306 LEU GLY THR VAL TYR ARG GLU LEU GLN LYS LEU SER LYS SEQRES 11 B 306 PHE ASP GLU GLN ARG THR ALA THR TYR ILE THR GLU LEU SEQRES 12 B 306 ALA ASN ALA LEU SER TYR CYS HIS SER LYS ARG VAL ILE SEQRES 13 B 306 HIS ARG ASP ILE LYS PRO GLU ASN LEU LEU LEU GLY SER SEQRES 14 B 306 ALA GLY GLU LEU LYS ILE ALA ASP PHE GLY TRP SER VAL SEQRES 15 B 306 HIS ALA PRO SER SER ARG ARG THR THR LEU CYS GLY THR SEQRES 16 B 306 LEU ASP TYR LEU PRO PRO GLU MET ILE GLU GLY ARG MET SEQRES 17 B 306 HIS ASP GLU LYS VAL ASP LEU TRP SER LEU GLY VAL LEU SEQRES 18 B 306 CYS TYR GLU PHE LEU VAL GLY LYS PRO PRO PHE GLU ALA SEQRES 19 B 306 ASN THR TYR GLN GLU THR TYR LYS ARG ILE SER ARG VAL SEQRES 20 B 306 GLU PHE THR PHE PRO ASP PHE VAL THR GLU GLY ALA ARG SEQRES 21 B 306 ASP LEU ILE SER ARG LEU LEU LYS HIS ASN PRO SER GLN SEQRES 22 B 306 ARG PRO MET LEU ARG GLU VAL LEU GLU HIS PRO TRP ILE SEQRES 23 B 306 THR ALA ASN SER SER LYS PRO SER ASN CYS GLN ASN LYS SEQRES 24 B 306 GLU SER ALA SER LYS GLN SER HET 626 A1389 32 HET ARS A1390 1 HET ARS A1391 1 HET 626 B1395 32 HET ARS B1396 1 HETNAM 626 4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5- HETNAM 2 626 DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE HETNAM ARS ARSENIC FORMUL 3 626 2(C23 H24 N6 O2 S) FORMUL 4 ARS 3(AS) FORMUL 8 HOH *194(H2 O) HELIX 1 1 ALA A 129 GLU A 131 5 3 HELIX 2 2 LYS A 166 ALA A 172 1 7 HELIX 3 3 VAL A 174 HIS A 187 1 14 HELIX 4 4 THR A 217 SER A 226 1 10 HELIX 5 5 ASP A 229 LYS A 250 1 22 HELIX 6 6 LYS A 258 GLU A 260 5 3 HELIX 7 7 ASP A 294 LEU A 296 5 3 HELIX 8 8 PRO A 297 GLU A 302 1 6 HELIX 9 9 LYS A 309 GLY A 325 1 17 HELIX 10 10 THR A 333 ARG A 343 1 11 HELIX 11 11 THR A 353 LEU A 364 1 12 HELIX 12 12 ASN A 367 ARG A 371 5 5 HELIX 13 13 MET A 373 GLU A 379 1 7 HELIX 14 14 HIS A 380 SER A 387 1 8 HELIX 15 15 ALA B 129 GLU B 131 5 3 HELIX 16 16 LYS B 166 GLY B 173 1 8 HELIX 17 17 HIS B 176 LEU B 188 1 13 HELIX 18 18 THR B 217 SER B 226 1 10 HELIX 19 19 ASP B 229 SER B 249 1 21 HELIX 20 20 LYS B 258 GLU B 260 5 3 HELIX 21 21 ASP B 294 LEU B 296 5 3 HELIX 22 22 PRO B 297 GLU B 302 1 6 HELIX 23 23 LYS B 309 GLY B 325 1 17 HELIX 24 24 THR B 333 ARG B 343 1 11 HELIX 25 25 THR B 353 LEU B 364 1 12 HELIX 26 26 ASN B 367 ARG B 371 5 5 HELIX 27 27 MET B 373 HIS B 380 1 8 HELIX 28 28 HIS B 380 SER B 387 1 8 SHEET 1 AA 5 PHE A 133 LYS A 141 0 SHEET 2 AA 5 GLY A 145 GLU A 152 -1 O VAL A 147 N LEU A 139 SHEET 3 AA 5 ILE A 158 PHE A 165 -1 O LEU A 159 N ALA A 150 SHEET 4 AA 5 ARG A 205 GLU A 211 -1 O VAL A 206 N LEU A 164 SHEET 5 AA 5 LEU A 196 HIS A 201 -1 N TYR A 197 O ILE A 209 SHEET 1 AB 2 LEU A 262 LEU A 264 0 SHEET 2 AB 2 LEU A 270 ILE A 272 -1 O LYS A 271 N LEU A 263 SHEET 1 AC 2 THR A 287 THR A 288 0 SHEET 2 AC 2 GLY A 291 THR A 292 -1 O GLY A 291 N THR A 288 SHEET 1 BA 5 PHE B 133 LYS B 141 0 SHEET 2 BA 5 GLY B 145 GLU B 152 -1 O VAL B 147 N LEU B 139 SHEET 3 BA 5 ILE B 158 PHE B 165 -1 O LEU B 159 N ALA B 150 SHEET 4 BA 5 ARG B 205 LEU B 210 -1 O VAL B 206 N LEU B 164 SHEET 5 BA 5 LEU B 196 HIS B 201 -1 N TYR B 197 O ILE B 209 SHEET 1 BB 2 LEU B 262 LEU B 264 0 SHEET 2 BB 2 LEU B 270 ILE B 272 -1 O LYS B 271 N LEU B 263 SHEET 1 BC 2 THR B 287 THR B 288 0 SHEET 2 BC 2 GLY B 291 THR B 292 -1 O GLY B 291 N THR B 288 LINK SG CYS A 247 AS ARS A1390 1555 1555 2.52 LINK SG CYS B 247 AS ARS B1396 1555 1555 2.41 LINK AS ARS B1396 O HOH B2026 1555 1555 2.65 CISPEP 1 ALA A 281 PRO A 282 0 -0.58 SITE 1 AC1 13 ALA A 160 LEU A 194 GLU A 211 TYR A 212 SITE 2 AC1 13 ALA A 213 PRO A 214 GLY A 216 ARG A 220 SITE 3 AC1 13 GLU A 260 LEU A 263 ALA A 273 HIS A 280 SITE 4 AC1 13 HOH A2005 SITE 1 AC2 2 CYS A 247 ARG A 255 SITE 1 AC3 1 CYS A 290 SITE 1 AC4 16 ALA A 385 ALA B 160 LEU B 194 LEU B 210 SITE 2 AC4 16 GLU B 211 TYR B 212 ALA B 213 PRO B 214 SITE 3 AC4 16 GLY B 216 ARG B 220 GLU B 260 LEU B 263 SITE 4 AC4 16 ALA B 273 HIS B 280 HOH B2001 HOH B2084 SITE 1 AC5 3 CYS B 247 ARG B 255 HOH B2026 CRYST1 71.127 89.445 94.037 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014059 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011180 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010634 0.00000 MTRIX1 1 -0.738570 0.249050 0.626490 9.75534 1 MTRIX2 1 0.283810 -0.728060 0.624010 43.98392 1 MTRIX3 1 0.611530 0.638670 0.467040 -50.51562 1